· Periodic Report
Q3 operating loss of KRW 4.3 billion on KRW 17.0 billion revenue (standalone)
Oncotic Therapeutics sold KRW 17.0 billion in the third quarter but lost KRW 4.3 billion from its main business, down from a profit a year earlier.
476060 · KOSDAQ · Based on DART filings
3 total · 20 per page
· Periodic Report
Oncotic Therapeutics sold KRW 17.0 billion in the third quarter but lost KRW 4.3 billion from its main business, down from a profit a year earlier.
· Shareholders' Meeting
Onconic Therapeutics Inc. will hold an extraordinary shareholders' meeting on November 26 to amend its articles and elect two independent directors. The voting record date is November 2.
· Shareholders' Meeting
Onconic Therapeutics Inc. will hold an extraordinary shareholders' meeting on November 26 to amend its articles and elect independent directors. Electronic voting runs until November 25.
Get app alerts for new disclosures from Onconic Therapeutics Inc..